TERRAZZAN, Anna
 Distribuzione geografica
Continente #
NA - Nord America 1.275
AS - Asia 1.090
EU - Europa 736
SA - Sud America 186
AF - Africa 42
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.334
Nazione #
US - Stati Uniti d'America 1.217
SG - Singapore 405
IT - Italia 324
CN - Cina 216
VN - Vietnam 161
BR - Brasile 129
HK - Hong Kong 106
DE - Germania 99
PL - Polonia 63
FI - Finlandia 45
JP - Giappone 42
FR - Francia 39
GB - Regno Unito 39
IN - India 38
CA - Canada 30
BD - Bangladesh 28
ID - Indonesia 23
AR - Argentina 22
NL - Olanda 21
MX - Messico 20
SE - Svezia 18
ZA - Sudafrica 18
RU - Federazione Russa 17
TR - Turchia 14
UA - Ucraina 14
CO - Colombia 13
ES - Italia 13
IQ - Iraq 11
AT - Austria 8
EC - Ecuador 7
PK - Pakistan 7
UZ - Uzbekistan 7
BE - Belgio 6
CH - Svizzera 6
LT - Lituania 6
MA - Marocco 6
CL - Cile 5
EG - Egitto 5
PS - Palestinian Territory 5
AU - Australia 4
IR - Iran 4
VE - Venezuela 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
KE - Kenya 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AL - Albania 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
IE - Irlanda 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
NG - Nigeria 1
PR - Porto Rico 1
PT - Portogallo 1
SN - Senegal 1
SR - Suriname 1
TG - Togo 1
TH - Thailandia 1
ZM - Zambia 1
Totale 3.334
Città #
Singapore 280
Ashburn 206
Dallas 186
San Jose 173
Hong Kong 100
Ferrara 94
Beijing 80
Santa Clara 76
New York 55
Warsaw 47
Ho Chi Minh City 45
Los Angeles 45
Hanoi 44
Council Bluffs 43
Munich 37
Tokyo 37
Lauterbourg 25
Helsinki 21
Turku 21
Falkenstein 19
Bologna 18
Shanghai 18
São Paulo 17
Chicago 16
Stockholm 16
Jakarta 15
Lodz 14
Orem 14
Brooklyn 13
Denver 13
Buffalo 12
Johannesburg 12
Haiphong 11
Hefei 11
Milan 11
Atlanta 10
Düsseldorf 10
Montreal 9
Poplar 9
Toronto 9
Da Nang 8
Parma 8
Chandler 7
Chennai 7
Frankfurt am Main 7
Manchester 7
Mumbai 7
Ottawa 7
Rome 7
Amsterdam 6
Biên Hòa 6
Boston 6
Leverano 6
London 6
Mexico City 6
Nuremberg 6
Tashkent 6
The Dalles 6
Bremen 5
Buenos Aires 5
Fairfield 5
Houston 5
Marigliano 5
Medellín 5
Paris 5
Phoenix 5
Princeton 5
Querétaro 5
Redondo Beach 5
Rio de Janeiro 5
San Francisco 5
Addison 4
Alta Gracia 4
Belo Horizonte 4
Charlotte 4
City of London 4
Delhi 4
Greenville 4
Kamagaya Shi 4
Kensington 4
Padua 4
Seattle 4
Vienna 4
Baghdad 3
Baku 3
Bekasi 3
Bogotá 3
Bonate Sopra 3
Brasília 3
Brussels 3
Bắc Ninh 3
Cairo 3
Cambridge 3
Dhaka 3
Ferrara di Monte Baldo 3
Forlì 3
Goiânia 3
Guarulhos 3
Istanbul 3
Kochi 3
Totale 2.175
Nome #
Drug repurposing and transposable elements: a new promising strategy to fight prostate cancer 271
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 200
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer 196
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 185
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 183
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 171
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells 167
Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways 156
Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors 153
Expanding circulating tumor cell detection beyond the EpCAM horizon 147
Alzheimer and purinergic signaling: Just a matter of inflammation? 143
Inhibition of Type 2 Transglutaminase significantly alters long noncoding RNAs expression in triplenegative breast cancer cell line. 134
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines 129
The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma 128
Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines 123
Type 2 Transglutaminase inhibition deregulates MIR210HG lncRNA expression impacting hypoxia­related genes in triple­negative breast cancer cell line 111
Enrichment of circulating tumor cells with microfluidics 110
Circulating microRNAs Suggest Networks Associated with Biological Functions in Aggressive Refractory Type 2 Celiac Disease 109
Prelude therapeutics: Transglutaminase type 2 inhibitors target Kv10.1 channels in triple negative MDA-MB-231 breast cancer cells 107
State-of-the-art in transposable element modulation affected by drugs in malignant prostatic cancer cells 106
Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response 104
Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer 88
Metabolic fingerprinting of breast cancer cell lines: discovering similarities and differences 76
Inhibition of cancerous properties of triple-negative MDA-MB-436 cells by targeting the K+ voltage-dependent Kv2.1 channel 51
PROTOCOL OPTIMIZATION FOR THE ISOLATION AND SINGLE-CELL CHARACTERIZATION OF CIRCULATING TUMOR CELLS 26
PROTOCOL OPTIMIZATION FOR THE ISOLATION AND SINGLE-CELL CHARACTERIZATION OF CIRCULATING TUMOR CELLS 26
Totale 3.400
Categoria #
all - tutte 13.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202252 0 7 17 0 3 0 1 3 2 0 7 12
2022/202353 6 3 2 0 5 3 4 7 9 6 4 4
2023/2024183 13 5 1 4 7 19 7 7 1 5 9 105
2024/2025874 66 26 74 59 72 66 26 64 114 74 127 106
2025/20262.238 162 93 319 250 349 198 257 138 188 277 7 0
Totale 3.400